Raptor Pharmaceuticals (RPTP) – A corporation that researches existing drugs to improve them through specialised drug targeting methods was up over 20% today after Lazard rated them a new “buy” and slapped a $16 price target on the stock.
I think you have to watch this name over the next few days because of the five bullet points below.
CLICK HERE for full article.
Business Insider Emails & Alerts
Site highlights each day to your inbox.